Table 3. Summary Table of the Discussed Upconversion Systems.
| sensitizer | mediator | annihilator | excitation (nm) | upconversion efficiency (%) |
|---|---|---|---|---|
| CdS/ZnS202 | 1-NCA | PPO | 405 | 5.2 ± 0.2 |
| CdS22 | 3-PCA | PPO | 405 | 10.4 |
| CsPbBr323 | 1-NCA | PPO | 443 | 10.2 |
| CsPbBrxI3-x81 | DPA* | DPA | 532 | 1.5 |
| CdSe76 | ACA | DPA | 532 | 9 ± 2 |
| CdSe207 | Ph-ADP | DPA | 488 | 16.9 |
| CuInS2/ZnS85 | ACA | DPA | 520 | 18.6 ± 0.9 |
| Si87,213 | anthracene | DPA | 488 | 15 |
| InP/ZnSe/ZnS65 | ACA | DPA | 530–590 | 10 ± 0.1 |
| CdSe (platelets)214 | ACA | DPA | 532 | 5.4 |
| CdTe (nanorods)215 | ACA | DPA | 520 | 4.3 |
| PbSe76 | rubrene | 808–980 | 0.01 | |
| PbSe77 | CPT | rubrene | 808 | 2.1 |
| PbS77 | CPT | rubrene | 808 | 1.7 |
| PbS/CdS75 | 5-CAT | rubrene | 808 | 8.4 ± 1 |
| PbS200 | 5-CAT | rubrene | 781 | 11.8 ± 1.1 |
| PbS78 | TES-ADT | 647–1064 | 0.012 |